Evoked potentials in neurological diagnosis by Mastaglia, F.L. & Carroll, W.M.
1678 BRITISH MEDICAL JOURNAL VOLUME 285 11 DECEMBER 1982
ture, and some dental equipment including the ultrasonic
cleaner. Investigations into the effect oftherapeutic radiation on
pacemaker function are conflicting,2 and the long-term effect
of radiation on electronic components is unknown, but, pro-
vided the pacemaker is protected, radiation may safely be given
to patients with pacemakers.
The patient faced with this daunting catalogue of potential
environmental dangers might well feel insecure. He may be
reassured that, though the list is long, the actual danger is, to
use Sowton's term, minimal.2 Nevertheless, patients with
pacemakers should be aware of the more likely sources of
interference so that they can learn to avoid them; manufac-
turers of electrical equipment should recognise the problem
and provide warning notices if electrical interference is likely,
and pacemaker manufacturers will, no doubt, continue to
develop means of filtering and rejecting interference signals.
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Evoked potentials in
neurological diagnosis
The functional integrity of specific cortical areas and of path-
ways in the central nervous system can be assessed by recording
the electrical potentials associated with specific sensory or
motor events. The procedure uses electronic averaging tech-
niques recording from surface electrodes placed over certain
areas of the brain or spinal cord. These methods provide a
non-invasive objective test which may disclose abnormalities
not apparent on clinical examination.
Evoked potentials have now established their place in the
diagnostic assessment of patients with several neurological
disorders, and their contribution in other disciplines is
continuing to be evaluated.' Visual, auditory, and somato-
sensory evoked potentials have been most widely used
diagnostically, while olfactory, cognitive, and movement-
associated potentials have yet to find routine application.
The main use of sensory evoked potentials has been in the
diagnosis ofmultiple sclerosis, in which they have proved useful
for confirming clinically suspected lesions of the visual,
auditory, and somatosensory pathways and-more important
-for detecting subclinical lesions. In so doing they may
reduce the need for more invasive procedures such as myclo-
graphy or angiography in some cases.2 Most useful has been
the pattern reversal visual evoked potential, which is abnormal
in 80-90°' of patients with a firm clinical diagnosis of multiple
sclerosis with or without previous visual symptoms,3 4 and in
30-500%" of patients with suspected or probable multiple
sclerosis.5 6 The characteristic finding is an increase in the
latency of the major positive component of the visual evoked
potential, which only rarely returns to normal. Small but
indistinguishable latency changes may, however, also occur in
patients with refractive errors7 or other ocular abnormalities,8
in pernicious anaemia,9 in hereditary ataxias,1( 11 in Charcot-
Marie-Tooth disease,'2 and in other forms of optic neuro-
pathy."3
Auditory brain stem and somatosensory evoked potentials
have been less useful than the visual evoked potential, but the
combined use of the three techniques provides the highest
yield of subclinical abnormalities in patients suspected of
suffering from multiple sclerosis.14 15 Abnormalities of the
auditory brain stem potentials have been found in up to 80%
of patients with definite multiple sclerosis'5 with a previous
history or clinical signs of lesions in the brain stem, and in up
to 500°, of patients without such signs.16 17 A few patients with
isolated optic neuritis are found to have abnormal auditory
brain stem potentials pointing to an additional lesion in the
brain stem and thereby increasing the likelihood of multiple
sclerosis (C Storey, "Role of evoked potentials in the in-
vestigation of optic neuritis"; presented at neuro-ophthal-
mology symposium, Melbourne, November 1981). Ab-
normalities of latency have proved the most useful measures,
especially comparisons of interpeak latency between the two
sides. Nevertheless, changes in latency in auditory brain stem
potential components are less definite than in the case of the
visual evoked potential and the abnormalities are in general
more labile; serial studies in patients with multiple sclerosis
have shown bidirectional variations.18
Abnormal sensory evoked potentials recorded over the scalp
or cervical spine, reflecting lesions of the dorsal column/
lemniscal sensory pathway, have been found in over 75"%0 of
patients with clinically definite multiple sclerosis and in a third
to a half of patients with probable or suspected multiple
sclerosis, including some without sensory symptoms or
141II) 20Tec
signs. 0 The combined use of upper and lower limb
stimulation and the calculation of conduction times in the
spinal and central portions of the somatosensory pathway has
increased the rate of detection of lesions and has helped in
locating them.2'
Abnormalities of evoked potentials may also occur in
disorders other than demyelinating diseases, though they are
less often of diagnostic value.22 23 Of particular importance is
the finding of normal evoked potentials in patients with
hysterical sensory deficits or malingering. Abnormalities of the
visual evoked potential may be found in patients with com-
pressive lesions of the optic nerve or chiasm such as pituitary
tumours or meningioma, and the site of compression may be
defined more precisely by the use of multichannel recordings
and hemifield stimulation.8 23 Characteristic patterns of
abnormality are also found in patients with toxic24 or hereditary
forms of bilateral optic neuropathy.25 Auditory brain stem
potentials have an important application in assessing auditory
acuity in infants or in retarded or uncooperative patients or
those with psychogenic hearing loss.26 They have also proved
useful in the diagnosis ofacoustic neuroma, abnormal responses
being found in most cases,27 and they may also provide
objective evidence of damage to the lower auditory pathway in
patients with ischaemia or a tumour of the brain stem and in
the postconcussional syndrome.28 30 They have been used in
evaluating brain stem function in coma and suspected brain
death31 but have yet to find general application in these
circumstances. Sensory evoked potentials may have a part to
play in assessing patients with lesions of the brachial plexus or
spinal roots32 and in determining the extent of traumatic spinal
cord lesions. Evoked potential techniques have also been used
to evaluate the severity of cerebral dysfunction after head
injury33 3 and in patients with metabolic encephalopathies35 36
and coma.37
Evoked potentials, therefore, provide a means of objective
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assessment of central nervous system function and yield
information which may help in diagnosis and in the manage-
ment of patients with a variety of neurological disorders. The
sensitivity of the techniques is likely to increase with further
developments in instrumentation and methods for analysis of
the response, with the development of new methods for
assessing the temporal properties of conduction in specific
pathways, and with improved definition of control groups.38
The analysis of late cortical components in patients with
dementia and cognitive disturbances3'" and recording of poten-
tials associated with limb movement40 I' are promising
developments with the possibility for clinical application and
warrant continuing investigation.
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BCG vaccination scars: an
avoidable problem?
Injections and vaccinations are most often given into the outer
aspect of the upper arm-on the grounds of safety and ease of
access. The use of this site may result in the formation ofhyper-
trophic or keloid scars' sufficiently unsightly for patients to
seek surgery. Smallpox vaccination was the most common
cause of these defects, but now that it is obsolete, BCG
(bacille Calmette Guerin) immunisation is left as the principal
offender. The incidence of hypertrophic or keloid scars result-
ing from BCG immunisation in Britain is not known, but
elsewhere in the world the incidence of hypertrophic scars has
been put at 28-330% and of keloid scars from 2% to 4%o2 3
Several factors influence the risk of scar formation and the
final appearance.4 The skin in some areas of the body has a
tendency to form hypertrophic scars-for example, the skin on
the deltoid, the sternum, and the upper back.5 Any infection,
especially if chronic, prolongs inflammation and increases the
risk of a bad scar. Pigmented skins are also more liable to scar
hypertrophy.
BCG inoculation results in the formation of a cell-mediated
immune response to the bacterium. The vaccine is given intra-
cutaneously (subcutaneous administration results in a cold
abscess), and after three weeks a bluish red papule appears at
